Articles from the ‘Media Releases’ Category
Latest price cuts add to PBS savings - 27 April
Thirteen medicines on the Pharmaceutical Benefits Scheme, accounting for more than 200 brands, will take price cuts of between 11 and 77 per cent from 1 August as part of the ongoing price disclosure system agreed between Medicines Australia and the Government. Read more…
CPI rise in pharmaceuticals due to PBS safety net - 24 April
The apparent surge in pharmaceutical prices included in today’s Consumer Price Index for the March quarter is easily explained by the mechanics of the Pharmaceutical Benefits Scheme safety net, Medicines Australia chief executive Dr Brendan Shaw confirmed today. Read more…
New report shows upturn in clinical trials numbers - 18 April
New figures from the Therapeutic Goods Administration (see below) show that for the first time in four years the number of clinical trials undertaken in Australia has grown, but that activity still lags behind the long-term average. Read more…
Winding back R&D tax credit would diminish investment and cost Australian jobs - 16 April
Winding back the R&D tax credit, which was introduced by the Federal Government last year, would discourage investment in Australia and cost high-value research jobs, Medicines Australia chief executive Dr Brendan Shaw said today. Read more…